Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Medicina Cardiovascular y Metabolómica, Monterrey, Nuevo León, México.
Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, Houston, Texas.
Med Res Rev. 2021 Jan;41(1):29-71. doi: 10.1002/med.21723. Epub 2020 Aug 17.
Cardiovascular diseases (CVDs) are the result of complex pathophysiological processes in the tissues comprising the heart and blood vessels. Inflammation is the main culprit for the development of cardiovascular dysfunction, and it may be traced to cellular stress events including apoptosis, oxidative and shear stress, and cellular and humoral immune responses, all of which impair the system's structure and function. An intracellular chaperone, heat shock protein 60 (HSP60) is an intriguing example of a protein that may both be an ally and a foe for cardiovascular homeostasis; on one hand providing protection against cellular injury, and on the other triggering damaging responses through innate and adaptive immunity. In this review we will discuss the functions of HSP60 and its effects on cells and the immune system regulation, only to later address its implications in the development and progression of CVD. Lastly, we summarize the outcome of various studies targeting HSP60 as a potential therapeutic strategy for cardiovascular and other diseases.
心血管疾病(CVDs)是构成心脏和血管的组织中复杂的病理生理过程的结果。炎症是导致心血管功能障碍发展的主要罪魁祸首,它可能源于包括细胞凋亡、氧化和切应力以及细胞和体液免疫反应在内的细胞应激事件,所有这些都会损害系统的结构和功能。热休克蛋白 60(HSP60)是一种细胞内伴侣蛋白,它可能既是心血管稳态的盟友,也是敌人;一方面提供对细胞损伤的保护,另一方面通过先天和适应性免疫触发有害反应。在这篇综述中,我们将讨论 HSP60 的功能及其对细胞和免疫系统调节的影响,然后再探讨其在 CVD 发展和进展中的意义。最后,我们总结了各种针对 HSP60 的研究结果,将其作为心血管疾病和其他疾病的潜在治疗策略。